Omega Healthcare Investors (NYSE:OHI) Sets New 12-Month High – Should You Buy?

Omega Healthcare Investors, Inc. (NYSE:OHI) shares reached a new 52-week high during trading on Wednesday . The stock traded as high as $42.08 and last traded at $41.98, with a volume of 51735 shares trading hands. The stock had previously closed at $41.88.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Truist Financial increased their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a report on Wednesday, September 4th. BNP Paribas raised Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a research report on Thursday. BMO Capital Markets boosted their target price on Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research note on Monday, October 7th. Berenberg Bank initiated coverage on shares of Omega Healthcare Investors in a research note on Friday, October 18th. They set a “buy” rating and a $45.00 price target for the company. Finally, Scotiabank boosted their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $39.70.

Omega Healthcare Investors Stock Down 0.2 %

The firm has a market capitalization of $10.94 billion, a P/E ratio of 31.20, a PEG ratio of 1.37 and a beta of 1.00. The firm’s 50 day moving average is $40.42 and its two-hundred day moving average is $35.89. The company has a debt-to-equity ratio of 1.19, a current ratio of 5.79 and a quick ratio of 5.79.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). The firm had revenue of $252.70 million during the quarter, compared to the consensus estimate of $205.92 million. Omega Healthcare Investors had a net margin of 34.41% and a return on equity of 9.19%. The business’s revenue was up 17.5% on a year-over-year basis. During the same period last year, the business earned $0.74 EPS. Research analysts predict that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Monday, November 4th will be issued a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 6.32%. The ex-dividend date is Monday, November 4th. Omega Healthcare Investors’s payout ratio is currently 197.06%.

Insiders Place Their Bets

In other news, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. In other news, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the sale, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at $4,025,000. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.37% of the company’s stock.

Hedge Funds Weigh In On Omega Healthcare Investors

Large investors have recently made changes to their positions in the company. Vanguard Group Inc. increased its position in Omega Healthcare Investors by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust’s stock worth $1,120,478,000 after buying an additional 165,105 shares during the period. Dimensional Fund Advisors LP increased its position in Omega Healthcare Investors by 7.9% during the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock worth $127,831,000 after acquiring an additional 272,299 shares during the period. Bank of New York Mellon Corp raised its stake in Omega Healthcare Investors by 4.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 3,240,025 shares of the real estate investment trust’s stock worth $110,971,000 after purchasing an additional 143,521 shares in the last quarter. LSV Asset Management boosted its holdings in Omega Healthcare Investors by 0.7% in the 2nd quarter. LSV Asset Management now owns 1,968,200 shares of the real estate investment trust’s stock valued at $67,411,000 after purchasing an additional 14,000 shares during the period. Finally, Daiwa Securities Group Inc. grew its position in shares of Omega Healthcare Investors by 1,030.8% during the 2nd quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust’s stock worth $32,384,000 after purchasing an additional 861,907 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.